Results 281 to 290 of about 119,295 (311)

BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers

Cancers, 2023
Claudio Tabolacci, Stefania Rossi, Maria Beatrice Arasi   +2 more
exaly  

BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis

Annals of Oncology, 2015
Alfredo Falcone, Fotios Loupakis, Salvatore Siena   +2 more
exaly  

Prevalence of BRAF V600E mutation in Chinese melanoma patients: Large scale analysis of BRAF and NRAS mutations in a 432-case cohort

European Journal of Cancer, 2012
Huan Yu, Xinan Sheng, Lu Si
exaly  

Clinical Development of BRAF plus MEK Inhibitor Combinations

Trends in Cancer, 2020
John M Kirkwood, Vivek Subbiah, Christina Baik   +2 more
exaly  

BRAF

2017
openaire   +1 more source

Cutaneous effects of BRAF inhibitor therapy: a case series

Annals of Oncology, 2013
Keith Flaherty, S Kraft
exaly  

On demand Gamma-Knife strategy can be safely combined with BRAF inhibitors for the treatment of melanoma brain metastases

Annals of Oncology, 2014
Caroline Gaudy-Marqueste, J Regis, S Monestier   +2 more
exaly  

BRAF MUTATIONS CONFERRING RESISTANCE TO BRAF INHIBITORS

2011
GARRAWAY LEVI, EMERY CAROLINE
openaire   +6 more sources

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

Acta Neuropathologica, 2011
Felix Sahm, Stefan Pusch, Andreas von Deimling   +2 more
exaly  

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

Cancer, 2011
Ben Tran, Jeanne Tie, Oliver Sieber
exaly